On September 4, 2009
Pfizer Rep Describes Pushing Zyvox With Flawed Data
Pfizer’s $2.3 billion settlement of the off-label Bextra case overshadows another case wrapped into the agreement, that of Ronald Rainero, a former district manager at Pfizer in New York City, regarding the antibiotic Zyvox.
0 Comments